Abbott Laboratories
IndexS&P 500 P/E40.07 EPS (ttm)1.09 Insider Own0.10% Shs Outstand1.51B Perf Week-1.22%
Market Cap65.77B Forward P/E19.89 EPS next Y2.20 Insider Trans-24.64% Shs Float1.50B Perf Month-3.92%
Income1.68B PEG4.25 EPS next Q0.68 Inst Own69.10% Short Float0.87% Perf Quarter3.41%
Sales20.61B P/S3.19 EPS this Y319.40% Inst Trans-0.16% Short Ratio2.71 Perf Half Y2.82%
Book/sh15.17 P/B2.88 EPS next Y-2.79% ROA5.60% Target Price46.50 Perf Year22.97%
Cash/sh3.24 P/C13.49 EPS next 5Y9.42% ROE9.90% 52W Range34.88 - 46.26 Perf YTD-2.46%
Dividend0.96 P/FCF37.73 EPS past 5Y-13.00% ROI8.00% 52W High-5.58% Beta0.62
Dividend %2.20% Quick Ratio1.30 Sales past 5Y-5.80% Gross Margin54.10% 52W Low25.21% ATR0.80
Employees69000 Current Ratio1.50 Sales Q/Q5.80% Oper. Margin13.90% RSI (14)43.02 Volatility1.57% 1.70%
OptionableYes Debt/Eq0.34 EPS Q/Q-29.30% Profit Margin11.40% Rel Volume1.01 Prev Close44.15
ShortableYes LT Debt/Eq0.16 EarningsJan 29 BMO Payout51.90% Avg Volume4.82M Price43.68
Recom2.30 SMA20-2.18% SMA50-1.83% SMA2004.85% Volume4,847,910 Change-1.06%
Sep-22-14Reiterated RBC Capital Mkts Outperform $44 → $48
Jul-17-14Reiterated Stifel Buy $42 → $47
Jul-17-14Reiterated Barclays Equal Weight $40 → $43
Mar-10-14Initiated Singular Research Sell $30
Dec-16-13Reiterated Deutsche Bank Hold $37 → $39
Oct-07-13Reiterated Stifel Buy $44 → $40
Jul-18-13Reiterated Barclays Equal Weight $35 → $37
May-28-13Reiterated RBC Capital Mkts Outperform $38 → $42
May-21-13Initiated Gabelli & Co Buy
Apr-19-13Reiterated RBC Capital Mkts Outperform $37 → $38
Apr-18-13Reiterated Stifel Buy $40 → $44
Apr-12-13Reiterated Deutsche Bank Hold $33 → $35
Feb-15-13Initiated Stifel Nicolaus Buy $40
Jan-11-13Reiterated UBS Buy $75 → $38
Jan-11-13Initiated Barclays Equal Weight $35
Jan-04-13Downgrade Deutsche Bank Buy → Hold $70 → $33
Jul-19-12Reiterated UBS Buy $68 → $72
Mar-19-12Reiterated UBS Buy $62 → $68
Mar-19-12Reiterated RBC Capital Mkts Outperform $60 → $68
Dec-09-11Downgrade Barclays Capital Overweight → Equal Weight $55 → $55
Jan-27-15 05:01PM  ABBOTT LABORATORIES Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib EDGAR Online
03:19PM  3 Stocks to Sell as Greece Concerns Intensify Euro Slide - Analyst Blog Zacks
Jan-21-15 10:50PM  J&J Seeks Billions in Trial Over Decade-Old Bidding War at Bloomberg
07:36PM  J&J's $7.2 bln claim against Boston Scientific now with U.S. judge Reuters
Jan-19-15 10:47PM  Tapping China's 'Silver Hair Industry' at The Wall Street Journal
Jan-15-15 09:00AM  Abbott Announces Results of Tender Offer and Consent Solicitation for CFR International SpA 5.125% Senior Notes due 2022 PR Newswire
Jan-14-15 05:45PM  DexCom Declares Preliminary Q4 '14 Revenues, Guides '15 - Analyst Blog Zacks
04:30PM  Moody's Upgrades Eight and Affirms 11 Classes of BACM 2007-3 at Moody's
07:00AM  Abbott Laboratories (ABT): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report Zacks
Jan-13-15 02:30PM  Street Talk: HLT, ABT, BBY & AMZN CNBC
09:26AM  Abbott Laboratories (ABT) Stock Lower Today After Jefferies Downgrade at TheStreet
Jan-12-15 10:44AM  Twelve Year Breakout Reaps Rewards at Forbes
Jan-08-15 09:00AM  Abbott Hosts Conference Call for Fourth-Quarter and Full-Year 2014 Earnings PR Newswire
Jan-05-15 10:43AM  It's all about oil, the euro and a strong dollar at CNBC
Jan-04-15 06:54PM  U.S. Healthcare Spending On Track To Hit $10,000 Per Person This Year at Forbes
Dec-31-14 01:31PM  Seek value, not momentum: Pro CNBC
Dec-30-14 09:00AM  Abbott Announces Early Results of Tender Offer and Consent Solicitation for CFR International SpA 5.125% Senior Notes due 2022 PR Newswire
Dec-23-14 05:04PM  ABBOTT LABORATORIES Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
03:33PM  Rising Services Spending Could Prop Up Healthcare, Tech ETFs ETF Trends
02:29PM  Chilean quits company boards to fight U.S. insider trading charges Reuters
12:32PM  How to play the third-quarter GDP beat at CNBC
Dec-22-14 04:30PM  Abbott Completes Acquisition of Topera, Inc. PR Newswire
02:32PM  U.S. regulator charges two with insider trading in Abbott deal Reuters
Dec-18-14 09:00AM  Abbott to Present at J.P. Morgan Healthcare Conference PR Newswire
Dec-17-14 06:52PM  Philips Buying Volcano To Boost Image-Guided Therapy at Investor's Business Daily
Dec-15-14 09:00AM  Abbott Commences Tender Offer and Consent Solicitation for CFR International SpA 5.125% Senior Notes due 2022 PR Newswire
Dec-12-14 01:02PM  Midday Movers: Exxon Mobil, Morgan Stanley & more at CNBC
12:59PM  Abbott Labs raises dividend to 24 cents AP
11:28AM  Abbott raises quarterly dividend to 24 cents a share from 22 cents at MarketWatch
11:18AM  Abbott Announces Increase in Quarterly Dividend PR Newswire
10:28AM  U.S. stocks renew fall as oil demand seen slowing at MarketWatch
12:00AM  Abbott Completes Acquisition of Veropharm PR Newswire
Dec-11-14 03:00AM  Abbott's Pioneering, Infectious Disease Testing Platform, IRIDICA, Now Available in Europe PR Newswire
Dec-10-14 12:01PM  Zoetis: An attractive business model Market Realist
08:55AM  Pharmalot, Pharmalittle: We're Reading About Mylan, AbbVie and Lots More!! at The Wall Street Journal
Dec-09-14 12:28PM  The Dollar and the Damage Done at
Dec-06-14 05:06AM  France, Germany suspend some drug approvals over Indian data Reuters
Dec-04-14 11:00AM  Impact of Malnutrition in U.S. at $157 Billion Annually PR Newswire
Dec-03-14 01:21PM  Bulls can't get enough of Abbott Labs optionMONSTER
11:54AM  Abbott Goes Beyond House of Brands, Boosts Parent Company Marketing at The Wall Street Journal
07:14AM  Abbott Labs attracts bullish trades optionMONSTER
Dec-02-14 06:36PM  Your first trade for Wednesday at CNBC
05:58PM  Your first trade tomorrow: CP, ABT, BBRY & F CNBC
05:22PM  Unusual Activity: Abbott Labs CNBC
Dec-01-14 10:24AM  Mylan to Manufacture, Distribute Gilead Sciences HIV Drug at The Wall Street Journal
10:09AM  Australian Diabetes Management Market and Diabetes Diagnostic Devices Market Spurted by $46 Million Between 2005 and 2013 PR Newswire
Nov-19-14 04:45PM  Zoetis Provides 2015 Earnings Guidance Below Estimates Zacks
Nov-18-14 03:15PM  Zoetis 2015 Guidance Misses As Buyout Theories Abound at Investor's Business Daily
Nov-17-14 06:11PM  Benzinga's M&A Chatter for Monday November 17, 2014 Benzinga
01:03PM  Midday movers: Allergan, CarMax, CBS & more at CNBC
10:00AM  People with Chronic Obstructive Pulmonary Disease (COPD) Who Received Nutrition Treatment in the Hospital Had Better Health Outcomes PR Newswire
08:32AM  [$$] Zoetis to Buy Abbott's Animal Health Assets at The Wall Street Journal
Nov-16-14 04:45PM  Extended anti-clotting therapy cut heart attacks after stent -study Reuters
04:45PM  Big Study Looks At Length of Drug Treatment After Stent Implantation at Forbes
Nov-14-14 03:42PM  Abbott Laboratories (ABT) Showing Signs Of Being Water-Logged And Getting Wetter at TheStreet
01:04PM  ABBOTT LABORATORIES Financials EDGAR Online Financials
Nov-13-14 04:35PM  Today's Market Overview. Yahoo Finance Blogs
Nov-10-14 01:54PM  DexCom G4 Platinum Software Gains FDA Nod, Shares Surge Zacks
Nov-08-14 07:07PM  10-Q for Abbott Laboratories Company Spotlight
Nov-06-14 05:02PM  ABBOTT LABORATORIES Files SEC form 10-Q, Quarterly Report EDGAR Online
03:17PM  State aid probes set to intensify in wake of leaks at Financial Times
03:40AM  India vs. China: The Battle for Global Manufacturing at BusinessWeek
Nov-04-14 09:00AM  Abbott to Present at Credit Suisse 2014 Healthcare Conference PR Newswire
07:21AM  Smith & Nephew's Bohuon seen as strong candidate for top Sanofi job Reuters
Oct-31-14 11:17AM  Mylan Rises On Q3 Earnings Beat, Affirms Abbott Deal at Investor's Business Daily
08:15AM  Billionaire Berg Funds New Prostate Test With Apple Rent at Bloomberg
Oct-30-14 03:40PM  Abbotts three big heart deals have one thing in common at Fortune
09:12AM  Abbott Labs Pays $250 Million for Topera in Heart Health Move TheStreet
09:12AM  Abbott Labs Pays $250 Million for Topera in Heart Health Move at TheStreet
Oct-29-14 11:10PM  INDIA PRESS-Johnson & Johnson may buy electrolyte drink ORS-L for 7 bln rupees - Times of India Reuters
10:20AM  [$$] Abbott Labs to Buy Topera at The Wall Street Journal
09:51AM  The Zacks Analyst Blog Highlights: AbbVie, Mylan, Abbott Laboratories, Actavis and Mallinckrodt Zacks
09:30AM  Abbott Expands Its Medical Device Business with Acquisition in Catheter-Based Electrophysiology Market PR Newswire
08:33AM  Deutsche Bank Upgrades Abbott Laboratories Benzinga
Oct-27-14 06:56PM  Amgen Q3 Earnings Beat Estimates; Guidance Mixed at Investor's Business Daily
01:43PM  What's boosting healthiest sector in S&P this year at CNBC
Oct-24-14 10:16AM  Here's what companies were saying about the economy this week Yahoo Finance Blogs
Oct-23-14 11:57AM  Abbott Laboratories (ABT) Earnings Report: Q3 2014 Conference Call Transcript at TheStreet
12:51AM  [$$] Abbott Sales Rise 5.8%; Mylan Terms Revised at The Wall Street Journal
Oct-22-14 06:43PM  Biogen, Thermo Reports Disappoint; Abbott Accelerates at Investor's Business Daily
06:22PM  Abbott, Mylan silent on why changing tax-inversion terms Reuters
04:59PM  Abbott Laboratories Conference Call Highlights Benzinga
12:18PM  Mylan-Abbott Inversion Deal Is On With Some Changes at The Wall Street Journal
10:22AM  Today's Unusual Social Activity Stock: Abbott Laboratories (ABT) at TheStreet
10:15AM  Abbott Labs' (ABT) Earnings Up Y/Y in Q3, Guidance Updated Zacks
09:28AM  [$$] Abbott Laboratories Sales Rise 5.8% at The Wall Street Journal
09:24AM  Abbott, Mylan back generics deal, tweak terms after tax rule change Reuters
09:00AM  Abbott Laboratories Earnings Call scheduled for 9:00 am ET today CCBN
08:50AM  ABBOTT LABORATORIES Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhib EDGAR Online
08:11AM  Abbott says third-quarter sales match forecasts Reuters
07:57AM  Abbott tops 3Q profit expectations AP
07:53AM  Abbotts Profit Rises as Nutrition Products Grow at Bloomberg
07:47AM  Abbott Labs shares rise after profit tops forecasts at MarketWatch
07:31AM  Abbott Reports Third-Quarter 2014 Results PR Newswire
07:07AM  Q3 2014 Abbott Laboratories Earnings Release - Before Market Open CCBN
Oct-21-14 08:30PM  [video]What to Watch on Wall Street for Wednesday, October 22nd 2014 at TheStreet
Oct-20-14 03:35PM  Will Abbott Labs (ABT) Miss on Earnings This Quarter? Zacks
11:00AM  New Large-Scale Study Will Look at How Nutrition Can Help Keep Patients from Returning to the Hospital PR Newswire
09:21AM  Jefferies Has 5 Stocks to Buy With Big Catalysts This Week at 24/7 Wall St.
Oct-16-14 04:30PM  Abbott Acknowledged by Science Magazine as a Top Employer PR Newswire
Abbott Laboratories manufactures and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome, intrahepatic cholestasis or depressive symptoms, gynecological disorders, dyslipidemia, hypertension, hypothyroidism, pain, fever, and inflammation; and regulates physiological rhythm of the colon, as well as provides hormone replacement therapy and anti-infective and influenza vaccines. The company's Diagnostic Products segment provides diagnostic systems and tests, such as immunoassay and clinical chemistry systems; assays for screening and diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and infectious diseases; hematology systems and reagents; genomic-based tests; informatics and automation solutions; and diagnostic systems and tests for blood analysis, as well as instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents. Its Nutritional Products segment offers pediatric and adult nutritional products, such as various forms of prepared infant and follow-on formula. The company's Vascular Products segment provides coronary, endovascular, vessel closure, and structural heart devices for the treatment of vascular diseases. Abbott Laboratories also offers blood glucose and glucose monitoring systems, test strips, and data management software and accessories for people with diabetes; and medical devices for the eye, such as cataract surgery, LASIK surgery, and contact lens care and dry eye products. The company primarily serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. It has strategic alliance with Fonterra Co-operative Group Ltd. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Contreras JaimeSenior Vice PresidentNov 25Option Exercise26.4651,6001,365,50481,736Nov 26 05:06 PM
Contreras JaimeSenior Vice PresidentNov 25Sale44.0751,6002,274,08030,136Nov 26 05:06 PM
WHITE MILES DChairman and CEOOct 29Option Exercise22.2738,034846,9031,452,559Oct 30 06:04 PM
WHITE MILES DChairman and CEOOct 29Sale42.7038,0341,624,0521,414,525Oct 30 06:04 PM
WHITE MILES DChairman and CEOOct 28Option Exercise22.27402,7668,968,3911,817,291Oct 30 06:04 PM
WHITE MILES DChairman and CEOOct 28Sale42.50402,76617,117,6341,414,525Oct 30 06:04 PM
Fussell Stephen RExecutive Vice PresidentSep 18Option Exercise22.7931,900726,872141,664Sep 19 05:10 PM
FREYMAN THOMAS CExecutive Vice PresidentJul 21Option Exercise24.0779,0001,901,828390,326Jul 22 05:03 PM
Landgraf John CExecutive Vice PresidentJun 03Option Exercise31.9118,203580,771113,334Jun 05 05:09 PM
Blaser Brian JExecutive Vice PresidentMar 03Sale39.011,44156,219102,895Mar 04 05:07 PM
Mason Heather LSenior Vice PresidentMar 03Sale38.952,19685,540118,410Mar 04 05:07 PM
Funck Robert EVice President, ControllerMar 03Sale38.971,41355,06862,926Mar 04 05:05 PM
ALLEN HUBERT LExecutive Vice PresidentMar 03Sale39.031,54360,22952,525Mar 04 05:06 PM
Foltz Charles DSenior Vice PresidentMar 03Sale38.951,58861,85465,318Mar 04 05:06 PM
ASHLEY RICHARD WExecutive Vice PresidentMar 03Sale39.002,09881,829333,072Mar 04 05:06 PM
Warmuth Michael JExecutive Vice PresidentMar 03Sale39.0116,484642,96615,851Mar 04 05:04 PM
Contreras JaimeSenior Vice PresidentMar 03Sale39.378,081318,16030,136Mar 04 05:05 PM
FREYMAN THOMAS CExecutive Vice PresidentMar 03Sale39.102,984116,686311,326Mar 04 05:05 PM
Landgraf John CExecutive Vice PresidentMar 03Sale39.3817,293681,05795,131Mar 04 05:04 PM
Doyle Katherine C.Senior Vice PresidentMar 03Sale39.016,639258,96447,525Mar 04 05:04 PM
Landgraf John CExecutive Vice PresidentFeb 18Option Exercise35.031,58355,452104,004Feb 19 06:54 PM
Contreras JaimeSenior Vice PresidentFeb 18Sale38.9662124,1911,067Feb 19 06:53 PM
Pavee Jean-YvesSenior Vice PresidentFeb 18Sale38.9748919,05429,479Feb 19 05:06 PM
ALLEN HUBERT LExecutive Vice PresidentFeb 18Sale39.0733313,00941,033Feb 19 05:06 PM
Landgraf John CExecutive Vice PresidentFeb 18Sale39.101,58361,899102,421Feb 19 06:54 PM
Landgraf John CExecutive Vice PresidentFeb 07Option Exercise32.1621,972706,529124,393Feb 11 05:05 PM
Landgraf John CExecutive Vice PresidentFeb 07Sale36.9621,972811,981102,421Feb 11 05:05 PM
Funck Robert EVice President, ControllerJan 31Option Exercise33.569,398315,40469,626Feb 04 05:02 PM
Funck Robert EVice President, ControllerJan 31Sale36.209,398340,19460,228Feb 04 05:02 PM
Warmuth Michael JExecutive Vice PresidentJan 29Option Exercise31.9111,430364,68451,917Jan 31 05:01 PM
Warmuth Michael JExecutive Vice PresidentJan 29Sale36.2111,430413,83240,487Jan 31 05:01 PM